Maria G. Atzori
Rome, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 19 publications
High-glucose stimulation triggers early transcription of a panel of proinflammatory mediators in rat Muller glia cells and retina primary explants.
Journal: Acta diabetologica
Published: October 02, 2024
Pharmacological inhibition of PDGF-C/neuropilin-1 interaction: A novel strategy to reduce melanoma metastatic potential.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: February 24, 2024
Targeting of PDGF-C/NRP-1 autocrine loop as a new strategy for counteracting the invasiveness of melanoma resistant to braf inhibitors.
Journal: Pharmacological research
Published: August 19, 2022
A novel and atypical NF-KB pro-inflammatory program regulated by a CamKII-proteasome axis is involved in the early activation of Muller glia by high glucose.
Journal: Cell & bioscience
Published: November 29, 2021
Targeting Tumor-Associated Macrophages to Increase the Efficacy of Immune Checkpoint Inhibitors: A Glimpse into Novel Therapeutic Approaches for Metastatic Melanoma.
Journal: Cancers
Published: September 17, 2020
Targeting the vascular endothelial growth factor receptor-1 by the monoclonal antibody D16F7 to increase the activity of immune checkpoint inhibitors against cutaneous melanoma.
Journal: Pharmacological research
Published: March 10, 2020
Role of VEGFs/VEGFR-1 Signaling and its Inhibition in Modulating Tumor Invasion: Experimental Evidence in Different Metastatic Cancer Models.
Journal: International journal of molecular sciences
Published: January 21, 2020
Role of VEGFR-1 in melanoma acquired resistance to the BRAF inhibitor vemurafenib.
Journal: Journal of cellular and molecular medicine
Published: September 02, 2019
Last Updated: 09/26/2026